SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Health state utilities in patients with advanced non-small-cell lung cancer in China
14 references·1 citing·44 second hop
Health state utilities in patients with advanced non-small-cell lung cancer in China (2018)Health state utilities in patients with a…Health state utilities in non–small cell lung cancer: An international study (2016)Health state utilities in non…Chinese Time Trade-Off Values for EQ-5D Health States (2014)Chinese Time Trade-Off Values…Health-Related Quality of Life and Utility in Patients with Advanced Non–Small-Cell Lung Cancer: A Prospective Cross-Sectional Patient Survey in a Real-World Setting (2013)Health-Related Quality of Lif…Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients (2012)Mapping EORTC QLQ-C30 onto EQ…Validation of the EQ-5D in a general population sample in urban China (2011)Validation of the EQ-5D in a …A Review and Meta-Analysis of Utility Values for Lung Cancer (2010)A Review and Meta-Analysis of…A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures (2009)A review of studies mapping (…The Impact of Chronic Hepatitis B on Quality of Life: A Multinational Study of Utilities from Infected and Uninfected Persons (2008)The Impact of Chronic Hepatit…Health state utility scores in advanced non-small cell lung cancer (2008)Health state utility scores i…Health state utilities for non small cell lung cancer (2008)Health state utilities for no…Health related quality of life in different states of breast cancer (2007)Health related quality of lif…EQ-SD: a measure of health status from the EuroQol Group (2001)EQ-SD: a measure of health st…Preferences for health outcomes and cost-utility analysis. (1997)Preferences for health outcom…Modeling Valuations for EuroQol Health States (1997)Modeling Valuations for EuroQ…Cost-Effectiveness of Domestic PD-1 Inhibitor Camrelizumab Combined With Chemotherapy in the First-Line Treatment of Advanced Nonsquamous Non–Small-Cell Lung Cancer in China (2021)Cost-Effectiveness of Domesti…The Measurement of Observer Agreement for Categorical Data (1977)Intraclass correlations: Uses in assessing rater reliability. (1979)A power primer. (1992)Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B (2014)Health-related quality of life and its influencing factors for patients with hypertension: evidence from the urban and rural areas of Shaanxi Province, China (2016)Measurement Properties of the EQ VAS Around the Globe: A Systematic Review and Meta-Regression Analysis (2021)EuroQol - a new facility for the measurement of health-related quality of life (1990)Measuring Health-Related Quality of Life (1993)Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients (2018)Cost-effectiveness of Osimertinib as First-line Treatment and Sequential Therapy for EGFR Mutation-positive Non-small Cell Lung Cancer in China (2019)The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer (2022)Cost-Effectiveness in Health and Medicine (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)Health-state utility values in breast cancer (2010)What Patients Can Tell Us: Topic Analysis for Social Media on Breast Cancer (2017)Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare (2018)Theory of Games and Economic Behavior (1945)Theory of Games and Economic Behavior (1946)Utilities of the EQ-5D (2009)Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study (2010)Magnetic Resonance Imaging Is Cost‐Effective for Hepatocellular Carcinoma Surveillance in High‐Risk Patients With Cirrhosis (2018)EuroQol: the current state of play (1996)The estimation of a preference-based measure of health from the SF-36 (2002)Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D (2005)Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting (2011)Valuation of the Child Health Utility 9D Index (2012)Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey (2014)China statistical yearbook (1988)Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) (2011)EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes (2016)EQ-5D-5L norms for the urban Chinese population in China (2018)Evaluation of health-related quality of life using EQ-5D in China during the COVID-19 pandemic (2020)Measurement of health state utilities for economic appraisal (1986)Quality of life and pharmacoeconomics in clinical trials (1996)Variations in population health status: results from a United Kingdom national questionnaire survey (1998)Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients WithEGFR-Mutated Advanced Non–Small Cell Lung Cancer (2018)A utility maximization model for evaluation of health care programs. (1972)Utility approach to measuring health-related quality of life (1987)First‐line atezolizumab in addition to bevacizumab plus chemotherapy for metastatic, nonsquamous non–small cell lung cancer: A United States–based cost‐effectiveness analysis (2019)Cost-Effectiveness Analysis of Durvalumab Plus Chemotherapy in the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (2021)Vignette-Based Utilities: Usefulness, Limitations, and Methodological Recommendations (2021)Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets (2012)Valuing health-related quality of life: An EQ-5D-5L value set for England (2017)Depression, chronic diseases, and decrements in health: results from the World Health Surveys (2007)
this work references cited by second hop

References

  • 2001EQ-SD: a measure of health status from the EuroQol Group5,610 cited
  • 1997Modeling Valuations for EuroQol Health States4,543 cited
  • 2009A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures517 cited
  • 2008Health state utilities for non small cell lung cancer407 cited
  • 2014Chinese Time Trade-Off Values for EQ-5D Health States354 cited
  • 2016Health state utilities in non–small cell lung cancer: An international study304 cited
  • 2007Health related quality of life in different states of breast cancer224 cited
  • 2008The Impact of Chronic Hepatitis B on Quality of Life: A Multinational Study of Utilities from Infected and Uninfected Persons162 cited
  • 2011Validation of the EQ-5D in a general population sample in urban China147 cited
  • 2013Health-Related Quality of Life and Utility in Patients with Advanced Non–Small-Cell Lung Cancer: A Prospective Cross-Sectional Patient Survey in a Real-World Setting147 cited
  • 2008Health state utility scores in advanced non-small cell lung cancer116 cited
  • 1997Preferences for health outcomes and cost-utility analysis.104 cited
  • 2010A Review and Meta-Analysis of Utility Values for Lung Cancer78 cited
  • 2012Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

66 cited

Cited by

  • 2021Cost-Effectiveness of Domestic PD-1 Inhibitor Camrelizumab Combined With Chemotherapy in the First-Line Treatment of Advanced Nonsquamous Non–Small-Cell Lung Cancer in China55 cited